Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids

This study has been completed.
Information provided by:
Genelabs Technologies Identifier:
First received: May 11, 2004
Last updated: January 10, 2008
Last verified: January 2008